Lipidil Supra, promising preventive effects for coronary heart disease
Published: 2005-12-02 06:56:00
Updated: 2005-12-02 06:56:00
Green Cross said that a new anti-cholesterol drug, Lipidil Supra (fenofibrate) showed a promising effect for the diabetic patients to prevent coronary heart diseases and to reduce significantly a risk of non-fatal myocardiac infarction.
Prof. Anthony Kitty of the University of Sydney in Aust...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
